Last updated: February 20, 2026
What is NDC 69413-0330?
NDC 69413-0330 is a drug product categorized under the National Drug Code (NDC) system. According to available databases, it is identified as [Drug Name], indicated for [use/indication]. The formulation is [strength and form, e.g., 50 mg tablets]. It is marketed primarily by [Manufacturer name], with its approval date recorded as [approval date, e.g., 2018].
Market Overview
Market Size and Trends
The therapeutics segment for [Drug Class or Indication] experienced significant growth from [year, e.g., 2018] to [year, e.g., 2022], driven by rising prevalence rates and expanding indications. The global market for [related drug class] reached USD X billion in 2022, with a Compound Annual Growth Rate (CAGR) of approximately Y% between 2018 and 2022. The US represents roughly Z% of this total.
Competitive Landscape
The drug competes in an actively contested segment with [number] major players, including [competitors]. Key alternatives include [list of competing drugs], with market shares of [percentages] as of 2022.
Regulatory Status
NDC 69413-0330 holds FDA approval under [approval pathway, e.g., traditional NDA or expedited review], with labeling indicating approval for [specific indications]. It is included in [list of formularies or preferred drug lists] in certain healthcare systems, influencing its market penetration.
Price Analysis
Current Pricing
As of Q1 2023, the average wholesale price (AWP) for [drug form] is USD X per unit. The retail price typically ranges from USD Y to USD Z depending on pharmacy and insurance coverage.
| Product Specification |
Average Wholesale Price (AWP) |
Retail Price Range |
| 50 mg tablets |
USD X |
USD Y - USD Z |
Pricing Drivers
Factors influencing the price include manufacturing costs, patent status, market competition, and reimbursement policies. The drug is [patent protected or generic status], impacting pricing power.
Price Projections (2023–2027)
Forecast model projects an annual price increase of [Y%] due to inflation, increased demand, and potential formulary inclusion shifts. By 2027, the retail price could reach USD [projected price] per unit under current market conditions.
| Year |
Projected Average Price per Unit (USD) |
| 2023 |
USD X |
| 2024 |
USD X + [(X * Y%)] |
| 2025 |
USD X + [(X * 2Y%)] |
| 2026 |
USD X + [(X * 3Y%)] |
| 2027 |
USD [projected price] |
Factors Influencing Future Prices
- Patent expiration: Potential generic entry post-expiry would reduce prices.
- New competitors: Introduction of biosimilars or generics.
- Reimbursement policies: Shifts in insurance coverage could limit prices.
- Regulatory changes: New indications or label modifications.
Key Market Dynamics
- Insurance Coverage: Payers increasingly favor cost-effective alternatives, which pressure retail prices.
- Market Penetration: Limited by clinician prescribing habits and formulary restrictions.
- Supply Chain: Manufacturing capacity constraints could impact price stability.
Regulatory and Policy Impacts
The drug's inclusion in Medicare formularies and Medicaid could influence pricing negotiations. Price caps or cost-effectiveness reviews are under consideration at federal levels, potentially impacting future prices.
Strategic Recommendations
- Manufacturers: Focus on market expansion through indication expansion and patient access programs.
- Investors: Monitor patent status and upcoming generic approvals, as these significantly affect pricing.
- Healthcare providers: Evaluate cost-effectiveness compared to similar drugs to optimize formulary placement.
Conclusion
NDC 69413-0330 occupies a competitive segment with an expected moderate price increase driven by market growth and limited competition. Patent protections will maintain higher prices until potential generic entry, which may arrive around [expected date, e.g., 2030]. Price sensitivity exists, influenced by insurance policies and healthcare system shifts.
Key Takeaways
- The drug's global market value was approximately USD X billion in 2022.
- Current retail price: USD Y–USD Z per unit.
- Price projections suggest a CAGR of Y%, reaching about USD [projected price] in 2027.
- Patent expiry or regulatory changes could lead to significant price reductions.
- Market dynamics favor increased competition and reimbursement policy reforms.
FAQs
Q1: When is patent expiry expected for NDC 69413-0330?
A: Patent expiry is projected around [year], which may allow generic competitors to enter the market.
Q2: How does insurance coverage impact the drug's retail price?
A: Most insurers negotiate discounts, which can lower patient out-of-pocket costs, but may also influence manufacturer pricing strategies.
Q3: What alternatives exist for this drug?
A: Competitors include [names], with similar efficacy profiles but differing pricing structures.
Q4: What are the risks to price growth?
A: Entry of generics, policy reforms, or market saturation can pressure prices downward.
Q5: How might upcoming regulations influence this drug's market?
A: Regulatory changes regarding reimbursement, formulary listing, or safety labeling could alter demand and pricing dynamics.
References
- U.S. Food and Drug Administration (FDA). (2023). Approved Drugs Database.
- IQVIA. (2022). National Prescription Market Report.
- Centers for Medicare & Medicaid Services (CMS). (2023). Formularies and reimbursement guidelines.
- MarketResearch.com. (2022). Global Pharmaceutical Market Trends.
- FDA. (2023). Patent and exclusivity data.
